• patients with genetic heart disease

    From ScienceDaily@1:317/3 to All on Tue Jan 25 21:30:46 2022
    patients with genetic heart disease
    A new, personalised heart modelling approach can predict abnormal heart rhythms and risk of sudden death in patients with hypertrophic cardiomyopathy, and may help determine who might benefit from a defibrillator.

    Date:
    January 25, 2022
    Source:
    eLife
    Summary:
    Modelling the heart in 3D using combined imaging techniques can
    help predict heart rhythm abnormalities, or arrhythmias, in patients
    with the genetic heart disease hypertrophic cardiomyopathy.



    FULL STORY ========================================================================== Modelling the heart in 3D using combined imaging techniques can help
    predict heart rhythm abnormalities, or arrhythmias, in patients with a
    genetic heart disease, shows a study published today in eLife.


    ==========================================================================
    The technique may one day help clinicians determine which patients with
    a condition called hypertrophic cardiomyopathy might benefit the most
    from a defibrillator.

    Hypertrophic cardiomyopathy is a disease that causes thickening and
    scarring in the heart muscles. Some people may not have clear symptoms
    of the condition, but others may develop heart rhythm abnormalities that
    can lead to sudden death.

    "There are ways to predict which patients are at risk of developing
    heart arrhythmias and who might benefit from a defibrillator, but these
    methods are not highly accurate," explains first author Ryan O'Hara,
    Research Assistant at the Trayanova Lab, Johns Hopkins University,
    Baltimore, Maryland, US. "We wanted to develop a more accurate
    and personalised approach for predicting abnormal heart rhythms in
    patients with hypertrophic cardiomyopathy." To do this, O'Hara and his colleagues combined two techniques: contrast- enhanced cardiac magnetic resonance imaging with late gadolinium enhancement, and post-contrast T1 mapping. Together, these methods enabled the team to construct digital, personalised replicas of patients' hearts, including specific scarring
    and thickening characteristics, and to evaluate the likelihood that they
    would go on to develop heart arrhythmias.

    Testing this approach in 26 patients showed that it accurately predicted
    which patients would develop abnormal heart rhythms approximately 80%
    of the time.

    "This is a substantial improvement over currently used prediction
    techniques, which are only accurate about half of the time," O'Hara says.

    Their work also showed that cardiac diffuse fibrosis -- lesions that are associated with progression to heart failure, but are rarely assessed in patients with hypertrophic cardiomyopathy -- can increase these patients' likelihood of developing an abnormal heart rhythm.

    More studies are now needed to confirm if this personalised modelling
    approach can be used to guide patient care before the technique can be
    adopted more widely.

    "If our technology is shown by larger studies to be superior to existing prediction methods, then it could help ensure that patients at high
    risk of heart arrhythmia receive a defibrillator or other appropriate intervention," concludes senior author Natalia Trayanova, the Murray
    B. Sachs Professor of Biomedical Engineering and Medicine at Johns
    Hopkins University. "Likewise, it could also ensure that patients
    who are unlikely to benefit are spared the risks of implantation." ========================================================================== Story Source: Materials provided by eLife. Note: Content may be edited
    for style and length.


    ========================================================================== Journal Reference:
    1. Ryan P O'Hara, Edem Binka, Adityo Prakosa, Stefan L Zimmerman,
    Mark J
    Cartoski, M Roselle Abraham, Dai-Yin Lu, Patrick M Boyle,
    Natalia A Trayanova. Personalized computational heart models
    with T1-mapped fibrotic remodeling predict sudden death risk in
    patients with hypertrophic cardiomyopathy. eLife, 2022; 11 DOI:
    10.7554/eLife.73325 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2022/01/220125112604.htm

    --- up 7 weeks, 3 days, 7 hours, 13 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)